Clinical course of sly syndrome (mucopolysaccharidosis type VII)

Journal of Medical Genetics

Volumn 53, Issue 6, 2016, Pages 403-418

  Montaño, Adriana M ^a   Lock Hock, Ngu ^b   Steiner, Robert D ^c,d,e   Graham, Brett H ^f   Szlago, Marina ^g   Greenstein, Robert ^h   Pineda, Mercedes ⁱ   Gonzalez Meneses, Antonio ^j   çoker, Mahmut ^k   Bartholomew, Dennis ^l   Sands, Mark S ^m   Wang, Raymond ^n,o   Giugliani, Roberto ^p   Macaya, Alfons ^q   Pastores, Gregory ^r   Ketko, Anastasia K ^s,t   Ezgü, Fatih ^u   Tanaka, Akemi ^v   Arash, Laila ^w   Beck, Michael ^w   Falk, Rena E ^x   Bhattacharya, Kaustuv ^y   Franco, José ^z   White, Klane K ^aa   Mitchell, Grant A ^ab   Cimbalistiene, Loreta ^ac   Holtz, Max ^a   Sly, William S ^a   more..

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HOSPITAL KUALA LUMPUR   (Malaysia)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d MARSHFIELD CLINIC   (United States)

^e UNIVERSITY OF WISCONSIN MADISON   (United States)

^f BAYLOR COLLEGE OF MEDICINE   (United States)

^g HOSPITAL DE NIÑOS RICARDO GUTIÉRREZ   (Argentina)

^h UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

ⁱ HOSPITAL SANT JOAN DE DÉU   (Spain)

^j HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^k EGE UNIVERSITY   (Turkey)

^l NATIONWIDE CHILDREN S HOSPITAL   (United States)

^m WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁿ CHILDREN S HOSPITAL OF ORANGE COUNTY   (United States)

^o UNIVERSITY OF CALIFORNIA   (United States)

^p HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^q HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^r NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^s UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^t CHILDREN S HOSPITALS AND CLINICS OF MINNESOTA   (United States)

^u GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^v OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^w UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^x CEDARS SINAI MEDICAL CENTER   (United States)

^y CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^z UNIVERSITY OF SÃO PAULO   (Brazil)

^aa SEATTLE CHILDREN S HOSPITAL   (United States)

^ab UNIVERSITY OF MONTREAL   (Canada)

^ac VILNIUS UNIVERSITY   (Lithuania)

more..

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT BETA GLUCURONIDASE; BETA GLUCURONIDASE;

ADOLESCENT; ADULT; ARTICLE; BONE DYSPLASIA; BONE MARROW TRANSPLANTATION; CHILD; CHILDHOOD; CLINICAL FEATURE; COGNITIVE DEFECT; DISEASE COURSE; DISEASE SEVERITY; ENZYME REPLACEMENT; FAMILY HISTORY; FEMALE; FETUS HYDROPS; GENETIC HETEROGENEITY; HEART DISEASE; HEPATOSPLENOMEGALY; HERNIA; HUMAN; INFANT; LUNG INSUFFICIENCY; MAJOR CLINICAL STUDY; MALE; MUCOPOLYSACCHARIDOSIS TYPE 7; ONSET AGE; PHENOTYPE; PRIORITY JOURNAL; SHORT STATURE; SURVIVOR; SYMPTOMATOLOGY; LYSOSOME STORAGE DISEASE; METABOLISM; PATHOLOGY; PRESCHOOL CHILD; QUESTIONNAIRE; YOUNG ADULT;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; GLUCURONIDASE; HUMANS; INFANT; LYSOSOMAL STORAGE DISEASES; MALE; MUCOPOLYSACCHARIDOSIS VII; PHENOTYPE; SURVEYS AND QUESTIONNAIRES; YOUNG ADULT;

EID: 84959263850     PISSN: 00222593     EISSN: 14686244     Source Type: Journal    
DOI: 10.1136/jmedgenet-2015-103322     Document Type: Article

References (82)

1. Sly WS, Quinton BA, McAlister WH, Rimoin DL. Beta glucuronidase deficiency: report of clinical, radiologic, and biochemical features of a new mucopolysaccharidosis. J Pediatr 1973;82:249-57
2. Neufeld EF, Muenzer J. The Mucopolysaccharidoses. In: Scriver CR, Beaudet A, Sly WS, et al. eds. The metabolic and molecular basis of inherited disease. Vol III. McGraw-Hill, 2001:3421-52
3. Nelson J. Incidence of the mucopolysaccharidoses in Northern Ireland. Hum Genet 1997;101:355-8
4. Pfeiffer RA, Kresse H, Bäumer N, Sattinger E. Beta-glucuronidase deficiency in a girl with unusual clinical features. Eur J Pediatr 1977;126:155-61
5. Guibaud P, Maire I, Goddon R, Teyssier G, Zabot MT, Mandon G. [Mucopolysaccharidesis Type VII resulting from beta-glucuronidase deficiency. Report of one family]. J Genet Hum 1979;27:29-43
6. Gitzelmann R, Wiesmann UN, Spycher MA, Herschkowitz N, Giedion A. Unusually mild course of beta-glucuronidase deficiency in two brothers (mucopolysaccharidosis VII). Helv Paediatr Acta 1978;33:413-28
7. Gehler J, Cantz M, Tolksdorf M, Spranger J, Gilbert E, Drube H. Mucopolysaccharidosis. VII. Beta-glucuronidase deficiency. Humangenetik 1974;23:149-58
8. Danes BS, Degnan M. Different clinical and biochemical phenotypes associated with b-glucuronidase defficiency. Birth Defects Orig Artic Ser 1974;X:251-7
9. Beaudet AL, DiFerrante NM, Ferry GD, Nichols BL Jr, Mullins CE. Variation in the phenotypic expression of β-glucuronidase deficiency. J Pediatr 1975;86:388-94
10. Meikle PJ, Hopwood JJ, Clague AE, Carey WF. Prevalence of lysosomal storage disorders. Jama 1999;281:249-54
11. Applegarth DA, Toone JR, Lowry RB. Incidence of inborn errors of metabolism in British Columbia, 1969-1996. Pediatrics 2000;105:e10
12. Poorthuis BJ, Wevers RA, Kleijer WJ, Groener JE, de Jong JG, van Weely S, Niezen-Koning KE, van Diggelen OP. The frequency of lysosomal storage diseases in The Netherlands. Hum Genet 1999;105:151-6
13. Baehner F, Schmiedeskamp C, Krummenauer F, Miebach E, Bajbouj M, Whybra C, Kohlschutter A, Kampmann C, Beck M. Cumulative incidence rates of the mucopolysaccharidoses in Germany. J Inherit Metab Dis 2005;28:1011-17
14. Malm G, Lund AM, Månsson JE, Heiberg A. Mucopolysaccharidoses in the Scandinavian countries: incidence and prevalence. Acta Paediatr 2008;97:1577-81
15. Lin HY, Lin SP, Chuang CK, Niu DM, Chen MR, Tsai FJ, Chao MC, Chiu PC, Lin SJ, Tsai LP, Hwu WL, Lin JL. Incidence of the mucopolysaccharidoses in Taiwan, 1984-2004. Am J Med Genet A 2009;149A:960-4
16. Nelson J, Crowhurst J, Carey B, Greed L. Incidence of the mucopolysaccharidoses in Western Australia. Am J Med Genet A 2003;123A:310-13
17. Whybra C, Mengel E, Russo A, Bahlmann F, Kampmann C, Beck M, Eich E, Mildenberger E. Lysosomal storage disorder in non-immunological hydrops fetalis (NIHF): more common than assumed? Report of four cases with transient NIHF and a review of the literature. Orphanet J Rare Dis 2012;7:86
18. Muenzer J. Overview of the mucopolysaccharidoses. Rheumatology (Oxford) 2011;50(Suppl 5):v4-12
19. Stone DL, Sidransky E. Hydrops fetalis: lysosomal storage disorders in extremis. Adv Pediatr 1999;46:409-40
20. Vervoort R, Islam MR, Sly WS, Zabot MT, Kleijer WJ, Chabas A, Fensom A, Young EP, Liebaers I, Lissens W. Molecular analysis of patients with beta-glucuronidase deficiency presenting as hydrops fetalis or as early mucopolysaccharidosis VII. Am J Hum Genet 1996;58:457-71
21. Van Dorpe J, Moerman P, Pecceu A, Van den Steen P, Fryns JP. Non-immune hydrops fetalis caused by beta-glucuronidase deficiency (mucopolysaccharidosis VII). Study of a family with 3 affected siblings. Genet Couns 1996;7:105-12
22. Speleman F, Vervoort R, van Roy N, Liebaers I, Sly WS, Lissens W. Localization by fluorescence in situ hybridization of the human functional beta-glucuronidase gene (GUSB) to 7q11.21?q11.22 and two pseudogenes to 5p13 and 5q13. Cytogenet Cell Genet 1996;72:53-5
23. Oshima A, Kyle JW, Miller RD, Hoffmann JW, Powell PP, Grubb JH, Sly WS, Tropak M, Guise KS, Gravel RA. Cloning, sequencing, and expression of cDNA for human beta-glucuronidase. Proc Natl Acad Sci USA 1987;84:685-9
24. Miller RD, Hoffmann JW, Powell PP, Kyle JW, Shipley JM, Bachinsky DR, Sly WS. Cloning and characterization of the human β-glucuronidase gene. Genomics 1990;7:280-3
25. Shipley JM, Miller RD, Wu BM, Grubb JH, Christensen SG, Kyle JW, Sly WS. Analysis of the 50 flanking region of the human beta-glucuronidase gene. Genomics 1991;10:1009-18
26. Shipley JM, Klinkenberg M, Wu BM, Bachinsky DR, Grubb JH, Sly WS. Mutational analysis of a patient with mucopolysaccharidosis type VII, and identification of pseudogenes. Am J Hum Genet 1993;52:517-26
27. Wu BM, Tomatsu S, Fukuda S, Sukegawa K, Orii T, Sly WS. Overexpression rescues the mutant phenotype of L176F mutation causing beta-glucuronidase deficiency mucopolysaccharidosis in two Mennonite siblings. J Biol Chem 1994;269:23681-8
28. Fukuda S, Tomatsu S, Sukegawa K, Sasaki T, Yamada Y, Kuwahara T, Okamoto H, Ikedo Y, Yamaguchi S, Orii T. Molecular analysis of mucopolysaccharidosis type VII. J Inherit Metab Dis 1991;14:800-4
29. Tomatsu S, Montaño AM, Dung VC, Grubb JH, Sly WS. Mutations and polymorphisms in GUSB gene in mucopolysaccharidosis VII (Sly Syndrome). Hum Mutat 2009;30:511-19
30. Islam MR, Vervoort R, Lissens W, Hoo JJ, Valentino LA, Sly WS. beta-Glucuronidase P408S, P415L mutations: evidence that both mutations combine to produce an MPS VII allele in certain Mexican patients. Hum Genet 1996;98:281-4
31. Tomatsu S, Fukuda S, Sukegawa K, Ikedo Y, Yamada S, Yamada Y, Sasaki T, Okamoto H, Kuwahara T, Yamaguchi S, Kiman T, Shintaku H, Isshiki G, Orii T. Mucopolysaccharidosis type VII: characterization of mutations and molecular heterogeneity. Am J Hum Genet 1991;48:89-96
32. Vervoort R, Buist NR, Kleijer WJ, Wevers R, Fryns JP, Liebaers I, Lissens W. Molecular analysis of the β-glucuronidase gene: novel mutations in mucopolysaccharidosis type VII and heterogeneity of the polyadenylation region. Hum Genet 1997;99:462-8
33. Chabas A, Giros ML, Guardiola A. Low beta-glucuronidase activity in a healthy member of a family with mucopolysaccharidosis VII. J Inherit Metab Dis 1991;14:908-14
34. Vervoort R, Gitzelmann R, Bosshard N, Maire I, Liebaers I, Lissens W. Low beta-glucuronidase enzyme activity and mutations in the human beta-glucuronidase gene in mild mucopolysaccharidosis type VII, pseudodeficiency and a heterozygote. Hum Genet 1998;102:69-78
35. Hall TA. BioEdit: A user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucl Acids Symp Ser 2001;41:95-8
36. Tamura K, Dudley J, Nei M, Kumar S. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) Software Version 4.0. Mol Biol Evol 2007;24:1596-9
37. Dickerman RD, Colle KO, Bruno CA, Jr, Schneider SJ. Craniovertebral instability with spinal cord compression in a 17-month-old boy with Sly syndrome (mucopolysaccharidosis type VII): a surgical dilemma. Spine 2004;29:E92-94
38. Fox JE, Volpe L, Bullaro J, Kakkis ED, Sly WS. First human treatment with investigational rhGUS enzyme replacement therapy in an advanced stage MPS VII patient. Mol Genet Metab 2015;114:203-8
39. Hoyme HE, Jones KL, Higginbottom MC, O'Brien JS. Presentation of mucopolysaccharidosis VII (beta-glucuronidase deficiency) in infancy. J Med Genet 1981;18:237-9
40. Sewell AC, Gehler J, Mittermaier G, Meyer E. Mucopolysaccharidosis type VII (beta-glucuronidase deficiency): a report of a new case and a survey of those in the literature. Clin Genet 1982;21:366-73
41. Teyssier G, Maire I, Damon G, Boyer S, Lauras B, Freycon F. [Mucopolysaccharidosis type VII. Clinical, radiological and biochemical studies in a neonatal case (author's transl)]. Arch Fr Pediatr 1981;38:603-4
42. Chabás A, Guardiola A. β-Glucuronidase deficiency: identification of an affected fetus with simultaneous sampling of chorionic villus and amniotic fluid. Prenat Diagn 1993;13:429-33
43. Sukegawa K, Orii T. Quantitation and biosynthesis of β-glucuronidase cross-reactive material in fibroblasts from patients with mucopolysaccharidosis VII. J Inherit Metab Dis 1985;8:145-6
44. Storch S, Wittenstein B, Islam R, Ullrich K, Sly WS, Braulke T. Mutational analysis in longest known survivor of mucopolysaccharidosis type VII. Hum Genet 2003;112:190-4
45. Groener JE, de Graaf FL, Poorthuis BJ, Kanhai HH. Prenatal diagnosis of lysosomal storage diseases using fetal blood. Prenat Diagn 1999;19:930-3
46. Lissens W, Dedobbeleer G, Foulon W, De Catte L, Charels K, Goossens A, Liebaers I. β-glucuronidase deficiency as a cause of prenatally diagnosed non-immune hydrops fetalis. Prenat Diagn 1991;11:405-10
47. Irani D, Kim HS, El-Hibri H, Dutton RV, Beaudet A, Armstrong D. Postmortem observations on beta-glucuronidase deficiency presenting as hydrops fetalis. Ann Neurol 1983;14:486-90
48. Nelson A, Peterson L, Frampton B, Sly WS. Mucopolysaccharidosis VII (β-glucuronidase deficiency) presenting as nonimmune hydrops fetalis. J Pediatr 1982;101:574-6
49. Kagie MJ, Kleijer WJ, Huijmans JG, Maaswinkel-Mooy P, Kanhai HH. beta-Glucuronidase deficiency as a cause of fetal hydrops. Am J Med Genet 1992;42:693-5
50. Molyneux AJ, Blair E, Coleman N, Daish P. Mucopolysaccharidosis type VII associated with hydrops fetalis: histopathological and ultrastructural features with genetic implications. J Clin Pathol 1997;50:252-4
51. Nelson J, Kenny B, O'Hara D, Harper A, Broadhead D. Foamy changes of placental cells in probable beta glucuronidase deficiency associated with hydrops fetalis. J Clin Pathol 1993;46:370-1
52. Stangenberg M, Lingman G, Roberts G, Ozand P. Mucopolysaccharidosis VII as cause of fetal hydrops in early pregnancy. Am J Med Genet 1992;44:142-4
53. Van Eyndhoven HW, Ter Brugge HG, Van Essen AJ, Kleijer WJ. β-glucuronidase deficiency as cause of recurrent hydrops fetalis: the first early prenatal diagnosis by chorionic villus sampling. Prenat Diagn 1998;18:959-62
54. Yamada S, Tomatsu S, Sly WS, Islam R, Wenger DA, Fukuda S, Sukegawa K, Orii T. Four novel mutations in mucopolysaccharidosis type VII including a unique base substitution in exon 10 of the β-glucuronidase gene that creates a novel 50-splice site. Hum Mol Genet 1995;4:651-5
55. Kooper AJ, Janssens PM, de Groot AN, Liebrand-van Sambeek ML, van den Berg CJ, Tan-Sindhunata GB, van den Berg PP, Bijlsma EK, Smits AP, Wevers RA. Lysosomal storage diseases in non-immune hydrops fetalis pregnancies. Clin Chim Acta 2006;371:176-82
56. Saxonhouse MA, Behnke M, Williams JL, Richards D, Weiss MD. Mucopolysaccharidosis Type VII presenting with isolated neonatal ascites. J Perinatol 2003;23:73-5
57. Capdeville R, Boissinot G, Graveleau D, Maroteaux P. [A new case of mucopolysaccharidosis type VII with major skeletal abnormalities]. Ann Pediatr (Paris) 1983;30:689-92
58. Gillett PM, Schreiber RA, Jevon GP, Israel DM, Warshawski T, Vallance H, Clarke LA. Mucopolysaccharidosis type VII (Sly syndrome) presenting as neonatal cholestasis with hepatosplenomegaly. J Pediatr Gastroenterol Nutr 2001;33:216-20
59. Nampoothiri S, Kappanayil M, Hiran KR, Sunitha V. Sly Disease: Mucopolysaccharidosis Type VII. Indian Pediatr 2008;45:859-61
60. Toda Y, Takeuchi M, Morita K, Iwasaki T, Oe K, Yokoyama M, Hirakawa M. Complete heart block during anesthetic management in a patient with mucopolysaccharidosis type VII. Anesthesiology 2001;95:1035-7
61. Young RD, Liskova P, Pinali C, Palka BP, Palos M, Jirsova K, Hrdlickova E, Tesarova M, Elleder M, Zeman J, Meek KM, Knupp C, Quantock AJ. Large proteoglycan complexes and disturbed collagen architecture in the corneal extracellular matrix of mucopolysaccharidosis type VII (Sly syndrome). Invest Ophthalmol Vis Sci 2011;52:6720-8
62. Vogler C, Levy B, Kyle JW, Sly WS, Williamson J, Whyte MP. Mucopolysaccharidosis VII: postmortem biochemical and pathological findings in a young adult with beta-glucuronidase deficiency. Mod Pathol 1994;7:132-7
63. Gniadek TJ, Singer N, Barker NJ, Spevak PJ, Crain BJ, Valle D, Halushka MK. Cardiovascular pathologies in mucopolysaccharidosis type VII (Sly Syndrome). Cardiovasc Pathol 2015;24:322-6
64. Pizzutillo PD, Osterkamp JA, Scott CI, Jr, Lee MS. Atlantoaxial instability in mucopolysaccharidosis type VII. J Pediatr Orthop 1989;9:76-8
65. de Kremer RD, Givogri I, Argaraña CE, Hliba E, Conci R, Boldini CD, Capra AP. Mucopolysaccharidosis type VII (beta-glucuronidase deficiency): a chronic variant with an oligosymptomatic severe skeletal dysplasia. Am J Med Genet 1992;44:145-52
66. Tokieda K, Morikawa Y, Natori M, Hayashida S, Mori K, Ikeda K. Intrauterine growth acceleration in the case of a severe form of mucopolysaccharidosis type VII. J Perinat Med 1998;26:235-9
67. White KK. Orthopaedic aspects of mucopolysaccharidoses. Rheumatology (Oxford) 2011;50(Suppl 5):v26-33
68. Wallace SP, Prutting CA, Gerber SE. Degeneration of speech, language, and hearing in a patient with mucopolysaccharidosis VII. Int J Pediatr Otorhinolaryngol 1990;19:97-107
69. O'Connor LH, Erway LC, Vogler CA, Sly WS, Nicholes A, Grubb J, Holmberg SW, Levy B, Sands MS. Enzyme replacement therapy for murine mucopolysaccharidosis type VII leads to improvements in behavior and auditory function. J Clin Invest 1998;101:1394-400
70. Vogler C, Levy B, Grubb JH, Galvin N, Tan Y, Kakkis E, PavloffN, Sly WS. Overcoming the blood-brain barrier with high-dose enzyme replacement therapy in murine mucopolysaccharidosis VII. Proc Natl Acad Sci USA 2005;102:14777-82
71. Huynh HT, Grubb JH, Vogler C, Sly WS. Biochemical evidence for superior correction of neuronal storage by chemically modified enzyme in murine mucopolysaccharidosis VII. Proc Natl Acad Sci USA 2012;109:17022-7
72. Rowan DJ, Tomatsu S, Grubb JH, Haupt B, Montano AM, Oikawa H, Sosa AC, Chen A, Sly WS. Long circulating enzyme replacement therapy rescues bone pathology in mucopolysaccharidosis VII murine model. Mol Genet Metab 2012;107:161-72
73. Sands MS, Vogler C, Torrey A, Levy B, Gwynn B, Grubb J, Sly WS, Birkenmeier EH. Murine mucopolysaccharidosis type VII: long term therapeutic effects of enzyme replacement and enzyme replacement followed by bone marrow transplantation. J Clin Invest 1997;99:1596-605
74. Liu G, Chen YH, He X, Martins I, Heth JA, Chiorini JA, Davidson BL. Adeno-associated virus type 5 reduces learning deficits and restores glutamate receptor subunit levels in MPS VII mice CNS. Mol Ther 2007;15:242-7
75. Mango RL, Xu L, Sands MS, Vogler C, Seiler G, Schwarz T, Haskins ME, Ponder KP. Neonatal retroviral vector-mediated hepatic gene therapy reduces bone, joint, and cartilage disease in mucopolysaccharidosis VII mice and dogs. Mol Genet Metab 2004;82:4-19
76. Fox JE, Volpe L, Bullaro J, Kakkis E, Sly WS. A one year follow-up of treatment with investigational recombinant human beta-glucuronidase enzyme replacement in a patient with an advanced stage mucopolysaccharidosis type VII. Mol Genet Metab 2015;114:359
77. Valayannopoulos V, Wijburg FA. Therapy for the mucopolysaccharidoses. Rheumatology (Oxford) 2011;50(Suppl 5):v49-59
78. Birkenmeier EH, Barker JE, Vogler CA, Kyle JW, Sly WS, Gwynn B, Levy B, Pegors C. Increased life span and correction of metabolic defects in murine mucopolysaccharidosis type VII after syngeneic bone marrow transplantation. Blood 1991;78:3081-92
79. Birkenmeier EH, Davisson MT, Beamer WG, Ganschow RE, Vogler CA, Gwynn B, Lyford KA, Maltais LM, Wawrzyniak CJ. Murine mucopolysaccharidosis type VII. Characterization of a mouse with beta-glucuronidase deficiency. J Clin Invest 1989;83:1258-66
80. Yamada Y, Kato K, Sukegawa K, Tomatsu S, Fukuda S, Emura S, Kojima S, Matsuyama T, Sly WS, Kondo N, Orii T. Treatment of MPS VII (Sly disease) by allogeneic BMT in a female with homozygous A619V mutation. Bone Marrow Transplant 1998;21:629-34
81. Bailey L. An overview of enzyme replacement therapy for lysosomal storage diseases. Online J Issues Nurs 2008;13:4
82. Sands MS, Barker JE, Vogler C, Levy B, Gwynn B, Galvin N, Sly WS, Birkenmeier E. Treatment of murine mucopolysaccharidosis type VII by syngeneic bone marrow transplantation in neonates. Lab Invest 1993;68:676-86